Inventor · disambiguated record
Carol K. Wada
Also filed as: WADA CAROL K
10 granted patents·19 pending applications·277 citations·filing 1997–2024
89Inventor score
Top patents by PatentIndex Score
29 records- 0197US6294573B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted Sep 25, 2001·131 cites·17 claims
- 0296US6235786B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted May 22, 2001·103 cites·13 claims
- 0388US2025152600A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 0487US9296741B2Bromodomain inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·7 cites·61 claims
- 0582US7202363B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2004·Granted Apr 10, 2007·12 cites·9 claims
- 0680US9050346B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jun 9, 2015·5 cites·20 claims
- 0780US2023158039A1Bromodomain inhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 0877US7468371B2Tricyclic pyrazole kinase inhibitorsABBOTT LAB·Filed 2005·Granted Dec 23, 2008·4 cites·20 claims
- 0973US9994581B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jun 12, 2018·2 cites·22 claims
- 1072US2021236508A1Bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 1170US7737160B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·2 cites·16 claims
- 1269US8273736B2Thienopyridine and furopyridine kinase inhibitorsBETSCHMANN PATRICK·Filed 2009·Granted Sep 25, 2012·1 cites·14 claims
- 1365US2018296566A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 1464US5985911AC-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretionABBOTT LAB·Filed 1997·Granted Nov 16, 1999·10 cites·13 claims
- 1562US2010063135A1Polyethylene glycol lipid conjugates and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1661US2010055168A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1761US2010055169A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1861US2009263407A1Cationic Lipids and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1958US2016143916A1Bromodomain inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 2053US2010104629A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2152US2010099738A1Polyethylene glycol lipid conjugates and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2248US2010076055A1Cationic Lipids and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2348US2009285881A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2446US2003225098A1Kinase inhibitorsFiled 2003·Application pending·0 cites
- 2544US2005026944A1Thienopyridine and furopyridine kinase inhibitorsFiled 2004·Application pending·0 cites
- 2640US2003199525A1Kinase inhibitorsFiled 2002·Application pending·0 cites
- 2739US2002007060A1Reverse hydroxamate inhibitors of matrix metalloproteinasesFiled 2001·Application pending·0 cites
- 2839US2002177594A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 2935US2002103192A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →